Skip to main content
OpenTrials

Clinical trial condition

Hypereosinophilic Syndrome

Explore clinical trials studying Hypereosinophilic Syndrome. Study availability and eligibility vary by location and protocol.

69 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Hypereosinophilic Syndrome trial results

Completed

Study of Mepolizumab Safety Syringe in Asthmatics

NCT03021304

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Cincinnati, Ohio, United States
  • GSK Investigational Site Orangeburg, South Carolina, United States
View all 15 locations
View Trial Details
Completed

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control

NCT02281318

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Fresno, California, United States
  • GSK Investigational Site Long Beach, California, United States
View all 144 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma

NCT01508936

Conditions
Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations
  • Investigational Site 861 Birmingham, Alabama, United States
  • Investigational Site 842 Homewood, Alabama, United States
  • Investigational Site 887 Jasper, Alabama, United States
  • Investigational Site 809 Tucson, Arizona, United States
View all 66 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma

NCT01270464

Conditions
Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations
  • Teva Investigational Site 12 Anaheim, California, United States
  • Teva Investigational Site 11 Fountain Valley, California, United States
  • Teva Investigational Site 43 Los Angeles, California, United States
  • Teva Investigational Site 4 Orange, California, United States
View all 89 locations
View Trial Details
Completed

Small Particle Steroids in Refractory Asthma

NCT01171365

Conditions
Asthma, Bronchial Diseases, Eosinophilia, +12 more
Locations
  • University Hospitals of Leicester NHS Trust Leicester, Leicestershire, United Kingdom
  • Nottingham University Hospitals NHS Trust Nottingham, Nottinghamshire, United Kingdom
View Trial Details

Related conditions